Abstract
The genus Phyllanthus belongs to the family Phyllanthaceae with large global distribution, with about 833 species, including Phyllanthus amarus and P. niruri. These species are widely used in traditional medicine because of their pharmacological potential. The objective of this work is to measure the potential of genus Phyllanthus after a technological and scientific monitoring to quantify and evaluate publications and patents related to Phyllanthus spp. with emphasis on P. amarus and P. niruri. The scientific monitoring summarizes morphotaxonomic, pharmacological, chemical, ethnomedicinal and biological aspects. The research was carried out based on papers found in journals deposited in the Web of Science and NCBI (PUBMED) databases and on patents found in the European Patent Office (ESPACENET), Google Patents and the National Institute of Industrial Property (INPI). The results show strong interest in the areas of Pharmacology and Medicinal Chemistry. Patents fall within the Human Necessities section by International Patent Classification as preparations for Medical, Dental or Hygienic Purposes. The summary of monitoring analysis demonstrates the potential pharmacological potential of P. amarus and P. niruri as agents to treat different types of diseases and a range of possibilities for clinical trials in several areas of health.
Keywords: Pharmacology, phytopharmaceutical, prospection, “quebra-pedra”, kidney-stone, medicinal.
Graphical Abstract
Current Traditional Medicine
Title:Biochemical and Pharmaceutic Properties of Genus Phyllanthus spp.: Focus on P. amarus Schum. & Thonn. and P. niruri L.
Volume: 7 Issue: 2
Author(s): Maria Francilene Souza Silva*, Fátima de Cássia E. de Oliveira, Maria Claudia dos Santos Luciano, Guilherme J. Zocolo and Claudia Pessoa
Affiliation:
- Federal University of Ceara, Nucleo de Pesquisa e Desenvolvimento de Medicamentos-NPDM, Rua Coronel Nunes de Mello 1000, CEP 60420-275, Fortaleza, CE,Brazil
Keywords: Pharmacology, phytopharmaceutical, prospection, “quebra-pedra”, kidney-stone, medicinal.
Abstract: The genus Phyllanthus belongs to the family Phyllanthaceae with large global distribution, with about 833 species, including Phyllanthus amarus and P. niruri. These species are widely used in traditional medicine because of their pharmacological potential. The objective of this work is to measure the potential of genus Phyllanthus after a technological and scientific monitoring to quantify and evaluate publications and patents related to Phyllanthus spp. with emphasis on P. amarus and P. niruri. The scientific monitoring summarizes morphotaxonomic, pharmacological, chemical, ethnomedicinal and biological aspects. The research was carried out based on papers found in journals deposited in the Web of Science and NCBI (PUBMED) databases and on patents found in the European Patent Office (ESPACENET), Google Patents and the National Institute of Industrial Property (INPI). The results show strong interest in the areas of Pharmacology and Medicinal Chemistry. Patents fall within the Human Necessities section by International Patent Classification as preparations for Medical, Dental or Hygienic Purposes. The summary of monitoring analysis demonstrates the potential pharmacological potential of P. amarus and P. niruri as agents to treat different types of diseases and a range of possibilities for clinical trials in several areas of health.
Export Options
About this article
Cite this article as:
Souza Silva Francilene Maria *, de Cássia E. de Oliveira Fátima , dos Santos Luciano Claudia Maria , Zocolo J. Guilherme and Pessoa Claudia , Biochemical and Pharmaceutic Properties of Genus Phyllanthus spp.: Focus on P. amarus Schum. & Thonn. and P. niruri L., Current Traditional Medicine 2021; 7 (2) . https://dx.doi.org/10.2174/2215083806666200217123358
DOI https://dx.doi.org/10.2174/2215083806666200217123358 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?
Current Radiopharmaceuticals Angiogenesis in Chronic Lymphocytic Leukemia
Current Angiogenesis (Discontinued) Q-TOF LC/MS-based Untargeted Metabolomics Approach to Evaluate the Effect of Folate-Conjugated Cyclodextrins on Triple-Negative Breast Cancer Cells
Current Pharmaceutical Analysis In Vitro and In Vivo Investigations into the Carbene Copper Bromide Anticancer Drug Candidate WBC4
Letters in Drug Design & Discovery Characterization of Carbonic Anhydrase Isozyme Specific Inhibition by Sulfamated 2-Ethylestra Compounds
Letters in Drug Design & Discovery Pharmacogenomics of Non-Small Cell Lung Cancer
Current Pharmacogenomics Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
Current Topics in Medicinal Chemistry D-Amino Acid Analogues of the Antimicrobial Peptide CDT Exhibit Anti- Cancer Properties in A549, a Human Lung Adenocarcinoma Cell Line
Protein & Peptide Letters A Functional Proteomic Approach to the Identification and Characterization of Protein Composition in Wheat Leaf
Current Proteomics Deciphering the Systems Biology of mTOR Inhibition by Integrative Transcriptome Analysis
Current Pharmaceutical Design AMPK Regulation of Glucose, Lipid and Protein Metabolism: Mechanisms and Nutritional Significance
Current Protein & Peptide Science When BMP Signalling Goes Wrong: The Intracellular and Molecular Mechanisms of BMP Signalling in Cancer
Current Signal Transduction Therapy Microaspiration in Intubated Critically Ill Patients: Diagnosis and Prevention
Infectious Disorders - Drug Targets Foamy Virus Vectors: An Awaited Alternative to Gammaretro- and Lentiviral Vectors
Current Gene Therapy Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review
Current Drug Targets Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers
Current Cancer Drug Targets Cancer Therapy: Targeting Mitochondria and other Sub-cellular Organelles
Current Pharmaceutical Design Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Current Cancer Drug Targets Benzamide Riboside, a Recent Inhibitor of Inosine 5-Monophosphate Dehydrogenase Induces Transferrin Receptors in Cancer Cells
Current Medicinal Chemistry